COVID-19 and other pulmonary parenchyma infections. research hub

ITPP as an adjunctive treatment for progressive respiratory failure in COVID-19 and other pulmonary parenchymal infections - a randomized, double-blind, non-commercial phase II clinical trial [BREATH2]

This study is looking into a new treatment called ITPP for serious lung infections like COVID-19. It aims to see if ITPP can help people breathe better when given alongside their usual care, and if it's safe to use.